Novo Nordisk to spend $4.1B to construct new plant for weight problems medicine in N.C.

Novo Nordisk sign on building, Danish pharmaceutical healthcare giant, production innovative drugs, obesity treatment Ozempic, pharmaceutical company innovation, Mainz, Germany June 15, 2024

Victor Golmer/iStock Editorial by way of Getty Pictures

  • Novo Nordisk (NVO) will make investments $4.1B to construct a 2nd fill and end production facility in Clayton, N.C. occupied with injectables medicines, together with present and long term ones for weight problems.
  • The advance comes as Novo, which makes the burden loss drug Wegovy (semaglutide), and


Risk Warning: 74-89% of retail investor accounts lose money when trading CFDs . You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money